MPI Research recently opened an office in Ahmedabad, India--the CRO's first location in India. Up until now, MPI has served the Indian clinical research market through its U.S. headquarters in Mattawan, Mich.
The new office will be managed by Bina Ramini, a research chemist and CRO consultant.
"The Indian biopharma market is booming, and having a local presence there will give our sponsors the support that they need," said MPI Research president and chief operating officer William Harrison in a company statement. "The knowledge and experience that Bina brings will allow us to work even more closely with our Indian sponsors in advancing their drug development programs."
MPI now has offices in India, the UK, France, Australia, Korea and Japan, as well as a joint venture in China with Medicilon, Medicilon/MPI Preclinical Research.